Product
AJU-A51
Aliases
AJU-A51 Placebo
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
Evaluate the Efficacy and Safety of the Combination of A51R3 and AJU-A51 Compared With the Combination of A51R3 and A51R2 in Patients With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2022-12-01